Human immediate early response 2 (IER2) is a nuclear protein that is implicated in cancer via transcriptional regulation of endothelial motility and adhesion via a FAK-dependent mechanism [24], thereby regulating tumor angiogenesis. Here, IER2 is linked to neoplasm.